HOW DO GLUCOCORTICOIDS, BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS AND DISEASE ACTIVITY IMPACT THE RISK OF STAPHYLOCOCCUS AUREUS BACTEREMIA IN RHEUMATOID ARTHRITIS PATIENTS? A NATIONWIDE NESTED CASE CONTROL STUDY IN THE DANISH DANBIO COHORT

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Documents

  • Fulltext

    Final published version, 223 KB, PDF document

Original languageEnglish
JournalAnnals of the Rheumatic Diseases
Volume81
Pages (from-to)571
Number of pages1
ISSN0003-4967
DOIs
Publication statusPublished - 2022

ID: 323832810